Yes, I mean, the role of surgery is rapidly changing. So here at the ESSO conference, we have been discussing the role of de-escalation in early melanoma, especially wide local excisions and if there is a need for central nodes in the future. Potentially, so that is one path we’re discussing and driving. The other path is what is the role of surgery in stage four disease. And that is increasing...
Yes, I mean, the role of surgery is rapidly changing. So here at the ESSO conference, we have been discussing the role of de-escalation in early melanoma, especially wide local excisions and if there is a need for central nodes in the future. Potentially, so that is one path we’re discussing and driving. The other path is what is the role of surgery in stage four disease. And that is increasing. And since we are in Madrid and ESMO was here last week, we have the new vaccine studies, more neoadjuvant treatments, but also more patients that live longer, but actually develop both local problems that can be solved with surgery. And we see an increase in it. So I think in melanoma now, we discuss both of these two things simultaneously, both escalation and de-escalation.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.